|
Symbol
|
LVBVLK | XRYLTQ | IHTEFG | LCDQLK | LTHCLK | OOJRCH | AAIDTQ | 1016BC | POMRCH | PRZRCH | PWCRCH | RMAA0V | RMBX0V | RMATBV | RMAZDV | LZMRCH | LZORCH | RMBJ7V | MAIRCH | RCDRCH |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | LUKB Autocallable Multi Reverse Convertible | Multi Reverse Convertible | Reverse Convertible | LUKB Multi Reverse Convertible | LUKB Softcallable Multi Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Reverse Convertible | Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Autocallable Reverse Convertible | Multi Vonti | Multi Vonti | Multi Vonti | Multi Vonti | Worst of Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Autocallable Reverse Convertible |
|
Sous-jacent
|
Nestlé S.A. / Swatch Group I / Swiss Life Hldg. N / Swiss RE AG | Compagnie Financière Richemont SA / Novartis Sandoz Basket / Roche PS / Swatch Group I / Swiss RE AG | Compagnie Financière Richemont SA / Lonza Group N / Sonova Hldg. AG / Swiss RE AG / Swisscom N | Partners Group Hldg. AG / Swiss Life Hldg. N / Swiss RE AG | ABB / Nestlé S.A. / Novartis AG / Roche PS / Swiss RE AG | Barry Callebaut AG / Nestlé S.A. / Roche PS / Swiss RE AG / UBS Group AG | Swiss Life / Swiss Re / Zurich | Nestlé S.A. / Sika AG / Swiss RE AG | Swiss Re / UBS / Zurich | Lonza Group N / Swiss Life Hldg. N / Swiss RE AG | Kühne & Nagel Intl. AG / Logitech International SA / Lonza Group N / Swiss RE AG / UBS Group AG | Swiss Life Hldg. N / Swiss RE AG / Zurich Insurance Group AG / Helvetia Baloise Holding AG | Schindler PS / Swiss RE AG / Swisscom N | Companie Financière Richemont SA / Geberit AG / Swiss RE AG | Nestlé S.A. / Partners Group Hldg. AG / Swiss RE AG | Holcim AG / Swiss RE AG / Lonza Group N | Swiss Life Hldg. N / Swiss RE AG / Helvetia Baloise Holding AG | Sika AG / Swiss RE AG / UBS Group AG / Zurich Insurance Group AG | Swiss Life / Swiss Re / Zurich | Novartis AG / Roche PS / Swiss Life Hldg. N / Swiss RE AG / Zurich Insurance Group AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
20.07.2026 | 22.09.2028 | 28.06.2029 | 03.06.2026 | 09.07.2027 | 15.07.2026 | 19.07.2027 | 06.11.2026 | 31.07.2026 | 24.02.2027 | 27.06.2029 | 26.04.2027 | 31.05.2027 | 25.06.2026 | 09.07.2026 | 31.07.2026 | 07.08.2029 | 19.08.2027 | 24.09.2027 | 26.09.2028 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
68,952 | 160,62 | 176,28 | 824,8414 | 58,7776 | 997,10 | 60,94 | 158,665 | 103,5375 | 416,78 | 364,13 | 113,44 | 103,04 | 407,30 | 791,945 | 110,6625 | 110,5875 | 142,30 | 103,9125 | 97,685 |
| rendement max. p.a. | 19,29% | 8,98% | - | 13,23% | 5,90% | 4,60% | 1,89% | 34,46% | 1,39% | 6,93% | 7,95% | 7,97% | 6,73% | 1,00% | 12,13% | 5,70% | 6,24% | 15,80% | 6,09% | 5,41% |
| Demande | 97,31 | 89,86 | 88,21 | - | 98,39 | 99,67 | 101,09 | 94,64 | 99,97 | 97,84 | 90,75 | 96,40 | 97,10 | 100,10 | 98,50 | 98,36 | 94,02 | 87,80 | 98,03 | 99,00 |
| Offre | 98,04 | 90,66 | - | - | 99,14 | 100,47 | 101,90 | 95,39 | 100,77 | 98,64 | 91,55 | 97,20 | 97,90 | 100,90 | 99,30 | 99,16 | 94,82 | 88,60 | 98,83 | 99,80 |